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The nonobese diabetic (NOD) mouse was established as an inbred strain in
1980 and proposed as a model of type I diabetes mellitus (1). By 6-8 wk of age,
mononuclear cells start infiltrating the periphery of pancreatic Langerhans' islets
of both males and females . Progressive invasion inside the islets occurs later and
is correlated with selective destruction of insulin-producing ß cells and with the
onset of clinically overt diabetes . Diabetes is first observed at 12 wk of age and
strongly predominates in females . By 30 wk of age, ^-70% of females have
become diabetic, while <20% of males develop overt disease (2). Several lines of
evidence suggest that diabetes in the NOD mouse is an autoimmune disease
mediated by T cells: First, Thy-1,2+ cells predominate in the cellular islet
infiltration (3) ; second, neonatal thymectomy prevents the disease (4) ; third,
NOD nu/nu mice do not develop diabetes (5) .
Further identification of immune cells involved in the destruction of insulin-
producing cells has been hindered by lack of suitable in vivo transfer models .
The NOD mouse has a particular MHC haplotype due to unique I-A specificity
(6) that prevents the inoculation ofNOD lymphoid cells into MHC-compatible
strains . Attempts to derive lines of nondiabetic mice from the original NOD
nucleus have also been unsuccessful . Recently, it has been shown (7) that the
transfer of spleen cells from diabetic mice into diabetes-prone NOD adults greatly
promoted the onset of overt diabetes, provided that the recipients had been
sublethally irradiated . In addition, adoptive transfer required recipients older
than 6-8 wk who, presumably, had already begun to self-damage their pancreatic
islets as inferred from histological studies (2) . This latter condition limits the
validity of the model to account for the whole history of ß cell destruction,
particularly in its initial stages .
In this study we show that diabetes can be adoptively transferred to NOD
neonates by spleen cells from diabetic NOD donors . Overt diabetes, which is
correlated with >90% of ß cell destruction (8, 9) occurred as early as 21 d of
age, at a time when pancreases of noninjected mice were still free of histological
changes . The susceptibility of the recipients to the transfer was limited in time
and declined after 3wk ofage. We also show that the neonatal model of transfer
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provides a sensitive in vivo assay to estimate the autoreactive potential of
lymphocytes from prediabetic NOD mice. Finally, we demonstrate that diabetes
can be transferred by purified T cells and that both L3T4+ and Lyt-2' T cells
are necessary to mediate the destruction of insulin-producing cells.
Materials and Methods
Mice.
￿
NOD mice were bred in our own facilities under specific pathogen-free condi-
tions. The spontaneous incidence of diabetes in our colony reaches 40% by 25 wk in
females, whereas overt diabetes remains rare in males. Histological examination shows
that up to 92% of males and 100% of nondiabetic females present destructive insulitis by
25 wk of age, although histological alterations are usually less severe in males.
Cells.
￿
Single cell suspensions were aseptically prepared in HBSS. 4-15 spleens were
pooled for each experiment. Diabetic donors were female mice used 1-3 wk after the
onset of glycosuria.
Cell Fractionation.
￿
T cells were purified by filtration through nylon wool columns and
subsequent panning for 45 min at 4°C over Petri dishes coated with rabbit anti-mouse
Igs (Miles Scientific Div., Naperville, IL) to remove residual contaminating B cells.
Depletion of Thy-1,2+ cells, L3T4+ cells, or Lyt-2' cells was accomplished by incubating
cells at a density of 2 x 10'/ml with relevant mAbs (see below) diluted in HBSS for 45
min at 4°C. The cells were then pelleted, resuspended at a density of 2 x 10'/ml in rabbit
complement diluted 1 :30, and incubated for 30 min at 37°C. Treated cells were washed
three times before injection into experimental animals. Rat IgM mAbs used for cell
depletion were culture supernatants diluted 1 :2 from clone4.221 for Thy-1,2+ cells (10),
clone 3.155 for Lyt-2' cells (11), and clone LICR-LAU-RL172.4 for L3T4' cells (12)
(with kind permission from Dr. MacDonald, Ludwig Institute for Cancer Research,
Lausanne, Switzerland). For Lyt-2' cell depletion, YTS 169.4, a rat IgG2b antibody with
specificity against Lyt-2' cells (Biosys, Compiegne, France), was added as an ascites fluid
diluted 1 :100 together with the supernatant of clone 3.155 .
Monitoring ofPurified Subpopulations.
￿
Contamination of purified subpopulations was
monitored by membrane fluorescence analysis, using fluorescein-conjugated Fab frag-
ments ofsheepanti-mouse Igs (Biosys) for membrane Ig' cells, and fluorescein-conjugated
purified ascites from clone 30-H12 for Thy-1,2' cells (13), 53-6.7 for Lyt-2' cells (13),
and GK 1 .5 for L3T4+ cells (14). Since 30-H12 and 53-6.7 compete, respectively, with
4.221 and 3.155 for immunofluorescence staining, an additional control was included. A
fluorescein-conjugated mouse anti-K mAb specific for rat light chain (Biosys) was used to
detect cells that might have escaped lysis by complement despite rat IgM-rc 4.221 or 3.155
mAbs fixation. In all depletion experiments, <1 % residual cells(among 3-4 x 102 counted
cells) were stained with either the corresponding antibody or the anti-rat K light chain
antibody. T cells purified after filtration through nylon wool columns and panning over
Petri dishes coated with rabbit anti-mouse Igs were composed of >90% Thy-1,2+ and
<I% membrane Ig-bearing cells.
Neonatal InjectionProtocol.
￿
Within 24 h after birth, neonates subjected to hypothermic
anesthesia (4 min at -20°C) were injected into the periorbital superficial vein with 0.05
ml cell suspension at the appropriate concentration under microscopic control. For
experiments designed to compare the effects of selective cell depletions or of various cell
numbers, representative treatments and controls were equally distributed within each
litter. Control litters were injected with spleen cells from nondiabetic NOD female mice
(8-15 wk old). Moreover, to monitor any potential consequences of the neonatal manip-
ulation on the subsequent onset of diabetes, additional controls included littermates
exposed to hypothermic anesthesia and injected with HBSS.
Monitoring of Neonatally Injected Mice.
￿
Mice were tested for glycosuria three times
weekly (Glukotest; Boehringer-Mannheim, Mannheim, Federal Republic of Germany)
and glycosuric mice were controlled for hyperglycemia using teststrips and a quantitative
colorimetric assay (Haemoglukotest and Reflolux F, Boehringer-Mannheim). Diabetic
mice showed permanent fasting hyperglycemia above 3 g/liter (normal 0.88 ± 0.08), andso
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FIGURE 1 .
￿
Incidence of diabetes in NOD females (open symbols) and males (closed symbols) .
(a) Broken lines, spontaneous incidence of diabetes in control groups : Neonatally HBSS-
injected mice (O, n = 31 ; ", n = 38), noninjected females (0, n = 64). Continuous lines,
incidence of diabetes in mice neonatally injected with 20 x 10 8 cells from pooled adult diabetic
female spleens (O, n = 35 ; ", n = 27). (b) Comparison of the autoimmune potential of
prediabetic NOD mice spleen cells versus that of various doses of diabetic spleen cells : Mice
neonatally injected with splenocytes from diabetics, 20 x 108 cells (O, n = 31 ; 0, n = 38), 5 x
108 cells (p, n = 11 ; /, n = 10), 1 .25 x 108 cells (O, n = 12; " , n = 10), or 20 x 108 spleen
cells from prediabetic 8-15-wk-old females (Q, n = 14 ; ~, n = 16) .
TABLE I
Age-related Susceptibility ofYoungNOD Recipients
to Diabetes Transfer
20 x 10 8 spleen cells from a pool of diabetic NOD mice, injected intrave-
nously . Successful transfers were scored up to 10 wk of life for mice
injected at 1 and 3 wk and up to 15 wk of life for mice injected at 5 wk .
Results
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usually died within 2-8 wk with overt diabetic symptoms, including polyuria, polydipsia,
and severe weight loss .
Histopathology.
￿
Paraffin sections (2 #M) of Bouin-fixed pancreases were stained with
hematoxylin and eosin . At least 20 Langerhans islets were examined for each specimen .
Adoptive Transfer ofDiabetes .
￿
Diabetes can be adoptively transferred toNOD
neonates by injection of adult female diabetic NOD spleen cells . As shown in
Fig . 1 and Table 1, up to 50% of mice injected neonatally with 20 X 106 cells
became diabetic by 10 wk of age . At this age spontaneous diabetes is still not
observed in the control littermates or in the other reference groups of the colony .
This age was thus chosen as the upper limit for scoring successful transfers . On
the other hand, >90% of the control mice of both sexes present already
histological signs ofinsulitis (data not shown)and therefore this parameter cannot
Age
Successful
Males
transfers of total mice
Females
injected
n % n
Id 11/27 42 20/35 57
2d 5/10 50 6/8 75
3d 3/7 43 2/9 22
4d 2/4 50 2/4 50
3 wk 1/19 5 13/31 42
5 wk 0/29 0 1/11 9826
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FIGURE 2. Photomicrographs of NOD mice pancreases. (a) Normal features in 4-wk-old
NOD mice; islets of Langerhansare intact and free of mononuclear cell infiltration . (b) Lesions
observed in a 4-wk-old male recipient neonatally injected with 20 x 10 6 spleen cells from
diabetic adult females ; severe mononuclear cell infiltration and destruction of the islet .
be used as a criterion of transfer among such animals . Some of the injected
animals showed the first symptoms of diabetes as early as the third or fourth
week of age . Destructive lymphocytic insulitiswasobserved in these mice whereas
a control group of 10 males and 10 females did not present any detectable
histological changes in their pancreas at 4 wk of age (Fig . 2) . Importantly,
diabetes could be transferred in both diabetes-prone females and diabetes-
resistant males. At 10 wk,42% of injected males and 57% of femaleshadbecome
diabetic . However, a marked difference between males and females occurred
later . The incidence of diabetes among females increased continuously until it
reached 80%, whereas it remained unchanged in males (Fig . 1) .
Diabetes Transfer by Spleen Cells from Diabetics is a Dose-dependent Phenome-
non . Only 19% of mice injected with 5 X 106 cells had become diabetic by 10
wk . Males and females showed similar proportions of successful transfers, but
again the rate of diabetes continued to increase after 10 wk in females, whereas
it remained constant in males (Fig . 1) . Diabetes was not adoptively transferred
with 1.25 X 106 cells . However this dose produced a significant increase in the
subsequent rate of diabetes in females but not in males (Fig . 1) .
Neonatal Injection of Spleen Cells from Nondiabetic NOD Mice.
￿
Groups of
newborn mice were also injected with spleen cells from young nondiabetic
females of 8, 10, 12, or 15 wk ofage . The results obtained in these experiments
were pooled to provide a substantial control group (Fig . 1) . As expected, no
adoptive transfer, as defined above, was observed . However a striking accelera-
tion of the onset of diabeteswas noted in these animalsafter 10 wk, as compared
with the noninjected control groups . The incidence rate was strikingly superim-
posable to that observed after injection with the low dose of 1 .25 X 106 spleen
cells from diabetics . Interestingly, spleen cells from older nondiabetic females of
18-19 wk of age could successfully transfer the disease into newborn mice . 6 of
12 recipients became diabetic within 10 wk (data not shown) .
Diabetes Transfer Depends upon the Age ofthe Recipients.
￿
To determine whetherInjected cells
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TABLE II
Effect ofSelective Thy-1,2' Spleen Cell Depletion
on Diabetes Transfer
TABLE III
Successful transfers of total
mice injected
Anti-Thy-1,2 + C'
￿
0/6*
C'
￿
7/11
20 X 106 pretreated viable spleen cells from a pool of six diabeticNOD
mice, injected intravenously into 1-d-old recipients (two litters born on
thesame day) .
* p<0.04 (Fisher exact test) .
Effects ofSelective L3T4' and Lyt-2' T Cell Depletion on Diabetes Transfer
Each experiment required simultaneous intravenous injection at birth of two litters with
pretreated viable spleen cells from a pool of 5-15 diabetic NOD mice . Exps . 1 and 3, 1 X
10 7 nylon wool-purifiedT cells, intact or after subset depletion ; Exps . 2 and 4, 2 X 10 7
spleen cells, intact or after subset depletion.
* Successful transfers of total mice injected
Cells injected were a mixture of 5 X 106 purified T cells depleted of L3T4' cells plus 5 X
106 purified T cells depleted of Lyt-2' cells.
4p< 0.02 and p< 0.001, respectively, for L3T4' and Lyt-2' T cell depletion (Fisher exact
test) .
the transfer of diabetes was due to a particular susceptibility of newborn mice,
older recipients were also injected with 20 x 106 spleen cells from diabetic mice .
The results of these experiments are shown in Table 1. Animals injected at the
age of 1, 2, 3, and4d showed a similar incidence of successful transfer at 10 wk
of age. Older animals were also tested as recipients . Females were still sensitive
to diabetes transfer at 3 wk of age, but became refractory around 5 wk . Males,
on the other hand, were already found resistant to adoptive transfer at 3 wk of
age .
Lymphocyte Subsets Depletion Experiments.
￿
Table 11shows that splenocytesfrom
diabetic mice, depleted of Thy-1,2' cells no longer transfer the disease . Con-
versely, positively selected nylon T cells are effective in transferring diabetes
(Table III, Exps . 1 and 3) . Table III compares, in addition, the capacity of T
cell subsets to transfer the disease . Both L3T4+ cell-depleted and Lyt-2+ cell-
depleted splenocytes failed to transfer the disease, whereas complement-treated
control spleen cells transferred diabetes . When the twoT lymphocyte subsets,
obtained after nylon wool passage and either anti-L3T4 or anti-Lyt-2 plus
complement treatment, were mixed together, total cell number being constant
Exp. Anti-L3T4 + C' Anti-Lyt-2 + C' C'
1 - 0/6* 6/11
2 0/6 - 1/6
3 0/3 0/4 4/4$
4 0/6 0/6 2/7
Total
L3T4+T cell depletion 0/15 - 7/17 4
Lyt2' T cell depletion - 0/16 12/224828
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amongthe injected groups, successful transfer of the disease wasrestored (Table
III, Exp . 3) .
Discussion
Increasing evidence for the role ofT cells in organ-specific autoimmunity has
accumulated over the past few years (reviewed in reference 15). Cell-transfer
experiments have provided the first direct evidence for T cell involvement in
various experimental autoimmune diseases . Similar evidence has been obtained
in the spontaneous autoimmune disease of the BB rat, another model of type I
diabetes mellitus . The disease could be transferred from diabetic to nondiabetic
BB rats provided that the injected spleen cells had been previously activated in
vitro with Con A (16) . However, the cells mediating the adoptive transfer have
not been further characterized .
The rationale for our experiments with NOD mice was to take advantage of
the delayed histological and clinical expression of the disease to develop a
neonatal model of adoptive transfer that could account for the whole history of
ß cell autoimmune destruction. We report here several findings concerning the
successful adoptive transfer ofNOD diabetes to neonates, the sensitivity of the
neonatal model as an in vivo assayto test theautoimmune potential ofnondiabetic
NOD mice, the age-related susceptibility of recipients to the transfer of the
disease, and the lymphocyte subsets involved in the cellular events leading to ß
cell destruction.
First, type I diabetes mellitus was transferred with spleen cells from diabetic
NOD mice . However, a considerable number of spleen cells were necessary to
produce a significant effect . Up to 20 x 106 cells were required to destroy, in
50% of the cases, the ß cells of a neonate . Several hypotheses may explain this
finding : (a) spleen may not be the elective organ for activated autoimmune cells;
attempts to transfer diabetes with lymphocytes isolated from the pancreas itself
are in progressandshould provide a more accurate estimation of the autoimmune
potentialof diabetic NOD mice lymphocytes ; (b) ß cell destruction inNOD mice,
as well as in BB rats and in diabetic humans, follows a chronic course so that
relatively fewautoimmune cells may be needed ata given moment of thedisease;
and (c) pancreases from neonates present two distinctive features, as compared
with adults, namely an increased ratio of endocrine cells and substantial regen-
eration potencies, as suggested by the presence of mitoses among islet cells (our
histological observations) and by functional regeneration experiments (17) .
Of interest was the finding that successful transfer could be achieved into both
males and females, whereas only females spontaneously develop overt diabetes
in our breeding colony . However, the occurrence of diabetes in the male group
stopped abruptly at 7 wk after transfer, whereas the incidence in females
continuously increased . Moreover, older male recipients became resistant to the
transfer earlier than females, at 3 wk of age . These features are probably related
to the natural resistance of males to overt diabetes . Sexual hormones, which
influence the incidence of diabetes in NOD mice (18), might account for these
differences . In addition, suppressor mechanisms are probably involved in the
resistance of males, as suggested by the promotion of overt diabetes after
cyclophosphamide treatment (19) . Our results suggest that these putative mech-BENDELAC ET AL .
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anisms may influence the long-term fate of the injected cells, but do not operate
in the first weeks of life .
Second, the neonatal model of transfer provides a sensitive assay to evaluate
the pathogenic effect ofNOD mouse lymphocytes . Although as few as 1 .25 x
106 spleen cells from diabetic mice do not transfer the disease within the first 10
wk, they nevertheless increase the rate of diabetes in female recipients . This
effect probably reflects the interference between adoptive transfer and sponta-
neous occurrence of the disease . Moreover, the finding that transfer of 20 x 106
spleen cells from 8-15-wk-old nondiabetic females can induce changes similar to
those provoked by 1 .25 x 106 cells from diabetics strongly suggests that the
autoimmune process has already begun in prediabetic animals . Cells from older
prediabetic females of 18-19 wk were able to transfer diabetes to neonate
recipients with a roughly equal rate of success as spleen cells from overtly diabetic
mice, indicating that the capacity of transferring the disease is not necessarily
linked with the presence of overt diabetes but that it is more probably related to
the duration and the severity of the insulitis as observed among 18-19-wk-old
prediabetic donors (data not shown) . Altogether, these data indicate that the
neonatal model of transfer provides a suitable in vivo assay to explore the
autoimmune potential ofNOD mice at various stages of their natural history .
Third, transfer experiments with recipients of various ages suggest that the
susceptibility to diabetes transfer is limited to the first weeks of life . 5-wk-old
animals ofboth sexes appeared to be refractory to the transfer, a result which is
in keeping with the work of Wicker et al . (7) . However, it seems paradoxical to
observe that animals of both sexes become resistant to diabetes transfer at the
very age when they notoriously begin to self-damage their pancreatic islets . At
variance with the adult models of transfer in NOD mice (7) and in BB rats (16),
the transfer inNOD newborns does not require prior irradiation ofthe recipients
or prior in vitro activation of the injected cells . These important features
probably reflect the unique immune status of the neonate . In addition, the
susceptibility of the neonate to the disease transfer provides direct evidence for
the expression early in life of the pancreatic self antigen(s) involved in the
autoimmune process . Therefore, the recent observations obtained in a transgenic
model of andislet autoimmunity, suggesting that the delayed expression of a
(transgenic) self antigen could be responsible for the occurrence ofautoimmune
lesions (20), cannot be extended to the NOD mouse model .
Fourth, transfer experiments with fractionated cell subsets yield clear-cut
conclusions . Both L3T4+and Lyt-2'T cells are necessary to successfully transfer
diabetes to neonates, and the mixture of the two separated subsets transfers the
disease . These results show that the neonatal transfer is T cell mediated and
probably involves cooperation between L3T4+ and Lyt-2' T cells . This dual
requirement has not been observed in other models ofT cell-mediated organ-
specific autoimmunity in which the effector cells have been characterized, such
as experimental autoimmune encephalomyelitis, adjuvant arthritis, and experi-
mental autoimmune thyroiditis . L3T4' cells from spleen, lymph node, or cell
lines and clones, presumably acting as inducer T cells, have been shown to
mediate these diseases, whereas Lyt-2' cells did not seem to represent effectors
in these models (15) .830
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Identification of the phenotype of theT cells involved in the transfer does not
allow, however, assigning a function to these T cell subsets in vivo . It is now
admitted that the expression of L3T4 or of Lyt-2 molecules is correlated
respectively with MHC class II or class I restriction of theT cell receptor rather
than with the helper versus cytotoxic or suppressor functions (21) . Therefore, it
may only be inferred from these results that ,8 cell destruction in the pancreas
implies the presentation of autoantigen(s) in the context of class I and class II
molecules at some stages of the autoimmune process . It is likely that L3T4+ cells
act as helper cells cooperating with activated Lyt-2+ cytotoxic cells, for example
by providing expansion signals such as IL-2 . The absence of transfer with L3T4+
cells alone would therefore indicate that the young recipients lack recruitable
Lyt-2+ cells . On the other hand, autoreactive Lyt-2+ effector cells are probably
in too limited a number in the inocula to produce the disease by themselves .
Alternatively, other roles may be putatively assigned to L3T4' and Lyt-2+ cells
in the destruction of S cells . L3T4+ cells could act as class I1-restricted auto-
reactive cytolytic cells, as has been shown in other systems (22), and Lyt-2+ cells
could inhibit the secretion of insulin as indicated by in vitro experiments (23) .
The identification oftwo cell subsets responsible for diabetes transfer does not
preclude the recruitment of host lymphocytic or nonlymphocytic cells . The
helper T cells might cooperate with host B lymphocytes and in turn mediate
complement-dependent or antibody-dependent cell-mediated cytotoxicity . Al-
though andislet cell autoantibodies are detected in NOD mice (24), several lines
of evidence argue against humoral effector mechanisms : (a) diabetes is not
transferred by mothers to their offspring (our personal observation of five litters
from insulin-treated diabetic mothers) ; (b) spleen cells depleted ofB lymphocytes
are as efficient as whole spleen cells in transferring the disease; and (c) B cells
are underrepresented among locally infiltrating cells in the pancreas (3) . Host
macrophages might also be involved in the process leading to the destruction of
,Q cells . T helper cells may secrete factors, such as macrophage-activating factor
or interferon, that promote macrophage cytotoxicity . In addition, IL-1 has been
shown to be selectively cytotoxic for ,B cells (25) .
Therefore, the diabetes of the NOD mouse may result from a complex
autoimmune process mediated by distinct T cell subsets . The neonatal model of
transfer should provide a basis for useful and more definitive studies of the
cellular events involved in the onset and regulation of autoreactivity against
insulin-producing cells in type I diabetes mellitus .
Summary
We have developed a model of syngeneic adoptive transfer for type I diabetes
mellitus ofNOD mice . This model consists in injecting spleen cells from diabetic
adult mice into newborn NOD recipients . 50% of recipients inoculated with 20
X 106 cells develop diabetes within the first 10 wk of life, at a time when none
of the control littermates have yet become diabetic . The earliest successful
transfers are observed at 3 wk of age, at a time when controls do noteven exhibit
histological changes in their pancreas . In addition we have shown that: (a) both
males and females can be adoptively transferred, despite the fact that males
rarely develop spontaneous diabetes in our colony ; (b) diabetes transfer is a dose-BENDELAC ET AL .
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dependentphenomenon that provides an in vivo assay forcomparing the autoim-
mune potential of spleen cells frommice at various stages of their natural history ;
(c) the susceptibility ofthe recipients to the transfer is limited in timeand declines
after 3 wk ; and (d) both L3T4+ and Lyt-2+ T cell subsets are necessary for the
successful transfer . The neonatal syngeneic transfer provides an effective model
for studies of the cellular events involved at regulatory and effector stages of
autoimmune type I diabetes .
We thank Ms . M . F . Richard for excellent technical assistance, J . Altman for managing
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